Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor CellsDominique Verhelle, Kyle Chan, Laura G. Corral et al.|Cancer Research|2007Cited by 232
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Kyle Chan, Dominique Verhelle et al.|Journal of Clinical Investigation|2008Cited by 180
Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2Gregory D. Ferguson, Kyle Chan, Kristen Jensen-Pergakes et al.|Journal of Clinical Immunology|2007Cited by 32
Targeted protein degradation of <scp>PDE4</scp> shortforms by a novel proteolysis targeting chimeraYuan Yan Sin, George S. Baillie, Aoife Giblin et al.|FEBS Journal|2024Cited by 7
Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.Laure Moutouh de Parseval, Kyle Chan, Helen Brady et al.|Blood|2005Cited by 3